Critical care issues in oncological surgery patients

Area of Science:

• Oncology
• Surgical Critical Care
• Gastroenterology

Background:

• Increasing life expectancy and cancer treatment advances lead to more oncology patients requiring aggressive surgical interventions.
• Cytoreductive surgery (CRS) combined with heated intraperitoneal chemotherapy (HIPEC) represents a multimodal approach in advanced cancer care.
• Surgical intensivists must manage complex postoperative critical care issues in these patients.

Purpose of the Study:

• To describe the Cytoreductive Surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC) technique.
• To discuss common postoperative complications and critical care challenges associated with CRS/HIPEC.
• To highlight the intensivist's role in managing high-risk oncology patients undergoing aggressive surgical treatments.

Main Methods:

• Review of the Cytoreductive Surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC) procedure.
• Discussion of common postoperative complications: anastomotic leaks, intestinal perforation, abscesses, intra-abdominal bleeding.
• Emphasis on critical care management, particularly sepsis and source control in the context of blunted physiologic responses.

Main Results:

• Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) are complex procedures with significant postoperative risks.
• Common complications include anastomotic leaks, perforation, abscesses, and bleeding.
• Sepsis leading to multiple organ failure is the primary cause of mortality in patients undergoing CRS/HIPEC.

Conclusions:

• The surgical intensivist plays a critical role in managing patients undergoing CRS/HIPEC.
• Vigilance for early detection and management of complications, especially sepsis and ensuring source control, is paramount.
• Effective critical care is essential for improving outcomes in oncology patients receiving aggressive multimodal surgical treatments.